Yu, C.; Hodge, A.M.; Wong, E.M.; Joo, J.E.; Makalic, E.; Schmidt, D.; Buchanan, D.D.; Hopper, J.L.; Giles, G.G.; Southey, M.C.;
et al. Association of FOXO3 Blood DNA Methylation with Cancer Risk, Cancer Survival, and Mortality. Cells 2021, 10, 3384.
https://doi.org/10.3390/cells10123384
AMA Style
Yu C, Hodge AM, Wong EM, Joo JE, Makalic E, Schmidt D, Buchanan DD, Hopper JL, Giles GG, Southey MC,
et al. Association of FOXO3 Blood DNA Methylation with Cancer Risk, Cancer Survival, and Mortality. Cells. 2021; 10(12):3384.
https://doi.org/10.3390/cells10123384
Chicago/Turabian Style
Yu, Chenglong, Allison M. Hodge, Ee Ming Wong, Jihoon Eric Joo, Enes Makalic, Daniel Schmidt, Daniel D. Buchanan, John L. Hopper, Graham G. Giles, Melissa C. Southey,
and et al. 2021. "Association of FOXO3 Blood DNA Methylation with Cancer Risk, Cancer Survival, and Mortality" Cells 10, no. 12: 3384.
https://doi.org/10.3390/cells10123384
APA Style
Yu, C., Hodge, A. M., Wong, E. M., Joo, J. E., Makalic, E., Schmidt, D., Buchanan, D. D., Hopper, J. L., Giles, G. G., Southey, M. C., & Dugué, P.-A.
(2021). Association of FOXO3 Blood DNA Methylation with Cancer Risk, Cancer Survival, and Mortality. Cells, 10(12), 3384.
https://doi.org/10.3390/cells10123384